Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

BBSRC Supports Call for Multi-Disciplinary Research Centres in Synthetic Biology

Published: Friday, May 03, 2013
Last Updated: Friday, May 03, 2013
Bookmark and Share
Up to six centres will be funded in two phases; three in this financial year and three next financial year.

The call is expected to launch in June, preceded by an 'Expression of Interest' (EoI) stage to which interested parties must submit a short application. The 'Expression of Interest' stage will be launching early May.

Following the announcement of £600M capital investment for Research Councils in the autumn 2012 statement, a joint call will shortly be launched for multidisciplinary research centres in synthetic biology.

The call has been developed by the RCUK Synthetic Biology Working Group, and will be supported by BBSRC and EPSRC, with BBSRC administering the call.


BBSRC and EPSRC will announce a joint call for proposals in the coming months (anticipated June).

Up to six centres will be funded in two phases:
1.    Three in the 2013/14 financial year
2.    Three in the 2014/15 financial year

The full call will be preceded by an 'Expression of Interest' (EoI) stage where interested parties must submit a short application. The EoI (maximum 3 sides) will outline:

•    initial information about potential partners
•    scientific scope
•    management arrangements
•    funding demand (capital and recurrent)
•    institutional support

Potential applicants will be invited to a workshop hosted by the funders that will provide full details of the call, application and assessment procedures. The EoI will enable the funders to gauge interest in the call and to tailor the information workshop accordingly.

This preannouncement is to provide eligible investigators with additional time to consider the details of a proposal and to begin the process of identifying potential partners.

A further announcement with additional details will be published for the EoI.


Synthetic biology can be defined as 'the design and engineering of biologically based parts, novel devices and systems as well as the re-design of existing natural biological systems.'

In 2012, there were a number of important developments of direct relevance to synthetic biology research in the UK including:

•    the publication of 'A synthetic biology roadmap for the UK' which contained key recommendations to support and develop the UK research and industrial communities
•    the establishment of the Synthetic Biology Leadership Council (bringing together stakeholders from government, funding agencies, academia and industry)
•    the announcement of significant government investment in synthetic biology in the 2012 autumn statement

To implement the roadmap recommendations, deliver on the investment from government and taking heed of the advice from the Synthetic Biology Leadership Council, BBSRC and EPSRC, together with input from ESRC, MRC and the TSB, have come together to establish multidisciplinary research centres for synthetic biology, in partnership with relevant higher education institutions. This is part of a larger "Synthetic Biology for Growth Programme", which also includes provision for training cohorts of skilled researchers, enhancing the UK's gene synthesis capability and accelerating the route to market for innovative synthetic biology research.


The multidisciplinary Synthetic Biology Research Centres (SBRCs) will possess the vision, breadth of intellectual leadership and research resources required to integrate disciplines including bioscience, engineering, chemistry and IT into programmes of synthetic biology research of the highest international quality. They will also integrate the research activities of experimental scientists with those working on ethical, legal, societal and other issues within the context of responsible innovation.

The UK roadmap recognised that SBRCs are necessary to build on the UK's strong research foundations in order to create bioengineered solutions to underpin the UK bioeconomy.

The SBRCs will focus on strategic areas relevant to one or more key industrial sectors that could include:

•    fine and speciality chemicals
•    life science technologies
•    energy
•    environment
•    sensors (including diagnostics)
•    agriculture and food
•    medicines and healthcare

Once established the SBRCs, working with the Research Councils, will form a coordinated programme of investment providing 'one-stop' access to resources and expertise, enhancing developmental opportunities for academia and industry alike.

Aims and purpose

The UK synthetic biology roadmap recognised a need to establish SBRCs to boost the national research capacity and diversify UK expertise, stimulating innovation and facilitating interfaces with industry and other key stakeholders.

It is envisaged that there will be a two-phase call for proposals, one in 2013 and the second in 2014, each establishing up to three SBRCs. Each phase will have a total of £10M capital funding available and each centre would receive additional recurrent funding (up to £2M per annum for five years).

The purpose of the SBRC's is to:

•    develop and sustain a programme of internationally competitive synthetic biology research focused on strategic areas relevant to one or more industry sectors
•    provide a strong collaborative culture and supportive physical environment to attract excellent scientists and engineers in the collective endeavour of multidisciplinary research relevant to synthetic biology
•    drive advancement in modern research techniques to underpin synthetic biology
•    lead the development of new technologies and methodologies
•    provide the essential equipment and facilities required to enable adoption and uptake of synthetic biology approaches and, where appropriate, make this available to the wider community
•    recognising the specific purpose and position of the SBRC's, and avoiding overlaps with other funded initiatives, contribute to an overall synthetic biology UK network that acts to integrate the full breadth of UK synthetic biology and offers outreach and exchange opportunities for academia and industry alike
•    enhance the output of trained postdoctoral researchers and specialised technical staff

To achieve the above, the SBRCs will require:

•    a clear vision and strategy for undertaking world-class synthetic biology research
•    strong and empowered leadership and direction
•    robust project management
•    meaningful engagement with industry and understanding of sector needs
•    long-term support and commitment from the host institution(s) to space, research facilities and staff
•    a concentration of relevant research facilities to enable the cutting edge research
•    the necessary multidisciplinary blend of the best researchers
•    the capability and motivation to develop and advance new technologies and methodologies and meet the needs of the broader research community
•    a commitment to outreach, wider researcher engagement, and training
•    flexibility in the deployment of funds
•    adherence to current appropriate international standards and contribute to the further development of these

Each centre will need to demonstrate an awareness of other relevant activities, initiatives and groupings in the synthetic biology landscape. These include, but are not limited to, the forthcoming Innovation and Knowledge Centre (IKC) in Synthetic Biology, established research groups in academia and industry, the synthetic biology networks, the Synthetic Biology Leadership Council, the TSB Special Interest Group and others. They must consider how best to integrate with the other stakeholders in terms of sharing of information and resources, building on complementarities and exploiting synergies, whilst avoiding duplication of effort.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genome-Editing Position Statement
A group of leading UK research organisations has today issued an initial joint statement in support of the continued use of CRISPR-Cas9 and other genome-editing techniques in preclinical research.
Monday, September 07, 2015
Expanding the DNA Alphabet: 'Extra' DNA Base Found to be Stable in Mammals
A rare DNA base, previously thought to be a temporary modification, has been shown to be stable in mammalian DNA, suggesting that it plays a key role in cellular function.
Thursday, June 25, 2015
Global Food Security (GFS) Develops New Funding Programme
New programme of research to tackle resilience of the food system.
Tuesday, June 02, 2015
£4M to Fund Important Food Crops from BBSRC and NERC
Research projects designed with industry partners to maximize impact.
Tuesday, June 02, 2015
Controlling Leaf Blotch Disease In Wheat
Scientists have found a genetic mechanism that could stop the spread of a "devastating" disease threatening wheat crops.
Thursday, February 05, 2015
Rising Temperatures Predicted to Lower Wheat Yields
An international consortium of researchers has used big data sets to predict the effects climate change on global wheat yields.
Friday, December 26, 2014
New Test For Detecting Horse Meat
New test compares differences in chemical compositions of the fat found in meats.
Tuesday, December 02, 2014
UK And India Collaborate On Future-Proof Crops
Drought-tolerant tomatoes, improved wheat and grass pea could provide crops for the future.
Friday, November 28, 2014
Drugs Used to Treat Lung Disease Work With the Body Clock
Scientists from The University of Manchester have discovered why medication to treat asthma and pneumonia can become ineffective.
Thursday, August 14, 2014
Researchers Use ‘Big Data’ Approach to Map the Relationships Between Human and Animal Diseases
EID2 database used to prevent and tackle disease outbreaks around the globe.
Thursday, July 17, 2014
TGAC at the Forefront of Next Generation Sequencing Capability
The Genome Analysis Centre adds two Illumina HiSeq 2500 machines to its platform suite.
Thursday, June 26, 2014
UK Diet and Health Research Awarded £4M
Funding awarded to six projects investigating diet and health to enable the food and drink industry to meet the needs of UK consumers.
Wednesday, June 25, 2014
Better Understanding of Disease Resistance Genes in Crops
Effector-triggered defence concept describes how plants protect themselves against the apoplast.
Friday, June 06, 2014
Investment Provides Access to the World’s Most Advanced Crystallography Technology
The UK community will benefit thanks to a £5.64M investment from UK research funders.
Tuesday, June 03, 2014
Public-private Research Partnership to Support Sustainable Agricultural Systems
The partnership will support projects that will help provide solutions to key challenges affecting the sustainability of the UK crop and livestock sectors.
Friday, May 23, 2014
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Self-Propelled Powder to Stop Bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Probing the Forces Involved in Creating The Mitotic Spindle
Scientists at The Rockefeller University reveal new insights into the mechanical forces that govern elements of the mitotic spindle formation.
Identifying Cancer’s Food Sensors May Help to Halt Tumour Growth
Oxford University researchers have identified a protein used by tumours to help them detect food supplies. Initial studies show that targeting the protein could restrict cancerous cells’ ability to grow.
Fatty Liver Disease and Scarring Have Strong Genetic Component
Researchers say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as much a consequence of genetics as environmental factors.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos